Introduction – Reform Doesn’t Fail by Accident When a bill with 104 co-sponsors, bipartisan support, and near-unanimous public backing dies in 18 hours, it’s not bad luck. It’s a plan. PBMs—pharmacy benefit managers—don’t just rely on slick talking points to protect their business model. They deploy one of the most powerful political arsenals in America: money. Campaign donations, lobbying contracts, sponsorships, PACs, and “friendly” trade groups are all part of the machine that keeps reform bottled up. Wisconsin is a case study in how the PBM playbook works.
The National Nerve Center – PCMA and AHIP At the national level, two lobbying giants run point for the PBM and insurance industries:
- PCMA – Pharmaceutical Care Management Association Represents the Big 3 PBMs (CVS Caremark, Express Scripts, OptumRx) and, since recently, Wisconsin’s own Navitus Health Solutions. PCMA’s mission is simple: stop laws that reduce PBM profits.
- AHIP – America’s Health Insurance Plans The umbrella lobby for health insurers, including UnitedHealthcare (OptumRx), Cigna (Express Scripts), and CVS Health (Caremark/Aetna). AHIP and PCMA often work in tandem, coordinating testimony, media statements, and “research reports” to give lawmakers talking points against reform. Both groups have national PACs that funnel millions into state and federal races, often targeting leadership positions and committee chairs who control health policy bills.
The Wisconsin Connection – Local Allies with Big Stakes In Madison, PBMs and insurers have powerful local partners:
- WMC – Wisconsin Manufacturers & Commerce Publicly opposed PBM reform while portraying it as bad for business. Behind the scenes, WMC operates as a paid insurance broker for UnitedHealthcare, earning substantial commissions for selling its plans. Since United owns OptumRx, one of the Big 3 PBMs, WMC’s financial interest aligns perfectly with the PBM lobby.
- Wisconsin Insurance Alliance Represents the state’s health and property insurers and lobbies against reforms that would increase oversight of insurance-related services like PBMs. These groups don’t just lobby—they fund campaigns. They know Wisconsin’s legislative structure gives disproportionate power to leadership and committee chairs. Targeting a few key figures can be more effective than trying to win over dozens of rank-and-file legislators.
The Playbook – How PBM Money Shapes Policy
- Target Leadership and Committees In Wisconsin, bills live or die based on decisions from the Speaker of the Assembly and key committee chairs. PBM and insurance lobby money flows disproportionately to these positions.
- Hire Insider Lobby Firms PCMA, AHIP, WMC, and insurers retain top lobbying firms with deep political relationships—often staffed by former legislative aides, ex-lawmakers, or party strategists who know exactly which buttons to push.
- Use Trade Groups as Fronts Groups like WMC provide political cover by framing opposition as “pro-business” rather than “pro-PBM.” This makes it easier for lawmakers to justify their votes to constituents.
- Flood Testimony with “Friendly” Experts During hearings, PBMs and allies bring in economists, consultants, and employer representatives who claim reform will raise costs—often without disclosing financial ties to PBMs or insurers.
- Pivot Messaging When one argument fails, the lobby quickly pivots. If “reform will raise taxpayer costs” stops working, they shift to “reform will limit patient choice” or “hurt small businesses.”
The 2021 Wisconsin Example In 2021, the PBM reform bill with 104 co-sponsors went through this exact process:
- PCMA, AHIP, WMC, and the Wisconsin Insurance Alliance met with leadership in the days before committee action.
- Overnight amendments stripped out spread pricing bans, made rebate pass-through optional, and erased anti-steering provisions.
- In just 18 hours over two days, a bill with overwhelming support was neutered. When it finally hit the floor, every Assembly member voted “yes” (except one senator later)—but they were voting on a gutted bill. The public saw “PBM reform passes,” but the lobby got exactly what it wanted: a law with no teeth.
Why This Works – And How to Break It The PBM lobby’s strength lies in:
- Concentration of Power – They only need to control a handful of leaders to control the process.
- Unified Messaging – PBMs, insurers, and allied trade groups speak with one voice.
- Financial Leverage – Campaign donations and industry sponsorships buy access and influence. Reformers can counter by:
- Publicly Naming Opponents – Voters need to know which leaders sided with PBMs and why.
- Following the Money – Trace campaign contributions from PCMA, AHIP, WMC, and insurance PACs to specific lawmakers.
- Broad Coalition Building – Unite pharmacists, employers, patient advocates, and taxpayers into one loud, consistent voice.
- Borrowing State Templates – Use proven legislative language from Arkansas, West Virginia, and North Dakota to counter lobby “cost” arguments.
Conclusion – The Fight Is Political, Not Technical PBM reform in Wisconsin isn’t failing because lawmakers don’t understand the issue—it’s failing because powerful lobbies are paying to make sure it does. Following the money exposes the real reason bills get gutted in hours instead of passed intact. It’s not about protecting patients, employers, or taxpayers — it’s about protecting a revenue stream that flows from high drug prices into corporate profits and political war chests. Shining a light on those connections isn’t just journalism — it’s the first step toward breaking the cycle. Because once voters see exactly who benefits from blocking reform, they can decide if those lawmakers still deserve their seat.

Daniel Strause is a CPA and graduate of UW–Whitewater with a BBA in Accounting. He began his career at Arthur Andersen as an auditor, where he developed a core principle of “trust but verify.” In 2003, he founded Hometown Pharmacies of Wisconsin and served as CFO for 20 years, gaining firsthand knowledge of the challenges in retail pharmacy—an industry where prices are controlled not by providers but by powerful middlemen, Pharmacy Benefit Managers (PBMs).
